Study of FL115 Injection for Advanced Solid Tumors
This trial tests an investigational drug called FL115, given as a shot under the skin, for people with advanced solid tumors who have already tried standard treatments and a type of immunotherapy called a checkpoint inhibitor. The goal is to see if FL115 can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have advanced solid tumors that have not responded to standard treatments, or you couldn't tolerate them.
- You have already tried a type of immunotherapy called a checkpoint inhibitor and your cancer worsened.
- You need to have at least one tumor that can be measured on a scan.
- You should be generally active, able to care for yourself, and have a life expectancy of at least 12 weeks.
- You must not have had certain previous treatments or medical conditions listed in the full criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FL115 combined with an immunotherapy (PD-1 antibody) for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if this combination can shrink tumors or slow their growth.
This study tests an experimental drug, BR113, for people whose cancer has spread and not responded to standard treatments. It may offer a new option for those with advanced solid tumors, and the trial helps determine if the drug is safe and effective.
This trial tests an investigational drug called HY07121, given as a shot under the skin, for people with advanced solid tumors that have not responded to standard treatments or for which no standard treatment exists. The study aims to see if the drug is safe and effective, and it may be an option if other treatments have stopped working.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This trial tests a new drug called FH-006 for people with advanced solid tumors that cannot be surgically removed or have spread. It aims to see if the drug is safe and effective.
Hear when a new Advanced Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.